1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Digital Therapeutics Market
2.2. Global Digital Therapeutics Market, By Application, 2023 (US$ Million)
2.3. Global Digital Therapeutics Market, By Sales Channel, 2023 (US$ Million)
2.4. Global Digital Therapeutics Market, By End-Use, 2023 (US$ Million)
2.5. Global Digital Therapeutics Market, By Geography, 2023 (US$ Million)
2.6. Attractive Investment Proposition by Geography, 2023
3. Digital Therapeutics Market: Competitive Analysis
3.1. Market Positioning of Key Digital Therapeutics Market Vendors
3.2. Strategies Adopted by Digital Therapeutics Market Vendors
3.3. Key Industry Strategies 4. Digital Therapeutics Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Digital Therapeutics Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape
5. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Preventive Applications
5.3.1.1. Prediabetes
5.3.1.2. Obesity
5.3.1.3. Nutrition
5.3.1.4. Lifestyle Management
5.3.1.5. Other Preventive Applications
5.3.2. Treatment/Care-related Applications
5.3.2.1. Diabetes
5.3.2.2. CNS Disorders
5.3.2.2.1. Mental Health Disorder
5.3.2.2.2. Other CNS Disorders
5.3.2.3. Chronic Respiratory Disorders
5.3.2.4. Musculoskeletal Disorders
5.3.2.5. Cardiovascular Diseases
5.3.2.6. Smoking Cessation
5.3.2.7. Medication Adherence
5.3.2.8. Gastrointestinal Disorders
5.3.2.9. Substance Use & Addiction Management
5.3.2.10. Rehabilitation & Patient Care
5.3.2.11. Other Treatment/Care-related Applications
8. North America Digital Therapeutics Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
8.3. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
8.4. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
8.5.Digital Therapeutics Market: By Region, 2022-2032, USD (Million)
8.5.1.North America
8.5.1.1. U.S.
8.5.1.1.1. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
8.5.1.1.2. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
8.5.1.1.3. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
8.5.1.2. Canada
8.5.1.2.1. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
8.5.1.2.2. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
8.5.1.2.3. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
8.5.1.3. Rest of North America
8.5.1.3.1. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
8.5.1.3.2. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
8.5.1.3.3. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
9. UK and European Union Digital Therapeutics Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
9.3. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
9.4. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
9.5.Digital Therapeutics Market: By Region, 2022-2032, USD (Million)
9.5.1.UK and European Union
9.5.1.1. UK
9.5.1.1.1. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
9.5.1.1.2. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
9.5.1.1.3. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
9.5.1.2. Germany
9.5.1.2.1. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
9.5.1.2.2. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
9.5.1.2.3. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
9.5.1.3. Spain
9.5.1.3.1. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
9.5.1.3.2. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
9.5.1.3.3. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
9.5.1.4. Italy
9.5.1.4.1. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
9.5.1.4.2. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
9.5.1.4.3. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
9.5.1.5. France
9.5.1.5.1. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
9.5.1.5.2. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
9.5.1.5.3. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
9.5.1.6. Rest of Europe
9.5.1.6.1. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
9.5.1.6.2. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
9.5.1.6.3. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
10. Asia Pacific Digital Therapeutics Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
10.3. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
10.4. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
10.5.Digital Therapeutics Market: By Region, 2022-2032, USD (Million)
10.5.1.Asia Pacific
10.5.1.1. China
10.5.1.1.1. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
10.5.1.1.2. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
10.5.1.1.3. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
10.5.1.2. Japan
10.5.1.2.1. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
10.5.1.2.2. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
10.5.1.2.3. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
10.5.1.3. India
10.5.1.3.1. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
10.5.1.3.2. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
10.5.1.3.3. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
10.5.1.4. Australia
10.5.1.4.1. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
10.5.1.4.2. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
10.5.1.4.3. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
10.5.1.5. South Korea
10.5.1.5.1. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
10.5.1.5.2. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
10.5.1.5.3. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
10.5.1.6. Rest of Asia Pacific
10.5.1.6.1. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
10.5.1.6.2. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
10.5.1.6.3. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
11. Latin America Digital Therapeutics Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
11.3. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
11.4. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
11.5.Digital Therapeutics Market: By Region, 2022-2032, USD (Million)
11.5.1.Latin America
11.5.1.1. Brazil
11.5.1.1.1. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
11.5.1.1.2. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
11.5.1.1.3. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
11.5.1.2. Mexico
11.5.1.2.1. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
11.5.1.2.2. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
11.5.1.2.3. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
11.5.1.3. Rest of Latin America
11.5.1.3.1. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
11.5.1.3.2. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
11.5.1.3.3. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
12. Middle East and Africa Digital Therapeutics Market, 2022-2032, USD (Million)
12.1. Market Overview
12.2. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
12.3. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
12.4. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
12.5.Digital Therapeutics Market: By Region, 2022-2032, USD (Million)
12.5.1.Middle East and Africa
12.5.1.1. GCC
12.5.1.1.1. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
12.5.1.1.2. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
12.5.1.1.3. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
12.5.1.2. Africa
12.5.1.2.1. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
12.5.1.2.2. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
12.5.1.2.3. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
12.5.1.3. Rest of Middle East and Africa
12.5.1.3.1. Digital Therapeutics Market: By Application, 2022-2032, USD (Million)
12.5.1.3.2. Digital Therapeutics Market: By Sales Channel, 2022-2032, USD (Million)
12.5.1.3.3. Digital Therapeutics Market: By End-Use, 2022-2032, USD (Million)
13. Company Profile
13.1. Pear Therapeutics
13.1.1. Company Overview
13.1.2. Financial Performance
13.1.3. Product Portfolio
13.1.4. Strategic Initiatives
13.2. Omada Health
13.2.1. Company Overview
13.2.2. Financial Performance
13.2.3. Product Portfolio
13.2.4. Strategic Initiatives
13.3. Akili Interactive
13.3.1. Company Overview
13.3.2. Financial Performance
13.3.3. Product Portfolio
13.3.4. Strategic Initiatives
13.4. Welldoc, Inc.
13.4.1. Company Overview
13.4.2. Financial Performance
13.4.3. Product Portfolio
13.4.4. Strategic Initiatives
13.5. 2Morrow, Inc
13.5.1. Company Overview
13.5.2. Financial Performance
13.5.3. Product Portfolio
13.5.4. Strategic Initiatives
13.6. Livongo Health, Inc. (Teladoc Health, Inc.)
13.6.1. Company Overview
13.6.2. Financial Performance
13.6.3. Product Portfolio
13.6.4. Strategic Initiatives
13.7. Propeller Health (ResMed)
13.7.1. Company Overview
13.7.2. Financial Performance
13.7.3. Product Portfolio
13.7.4. Strategic Initiatives
13.8. Fitbit LLC
13.8.1. Company Overview
13.8.2. Financial Performance
13.8.3. Product Portfolio
13.8.4. Strategic Initiatives
13.9. Mango Health
13.9.1. Company Overview
13.9.2. Financial Performance
13.9.3. Product Portfolio
13.9.4. Strategic Initiatives
13.10. Canary Health
13.10.1. Company Overview
13.10.2. Financial Performance
13.10.3. Product Portfolio
13.10.4. Strategic Initiatives
13.11. Noom, Inc.
13.11.1. Company Overview
13.11.2. Financial Performance
13.11.3. Product Portfolio
13.11.4. Strategic Initiatives
13.12. Hygieia
13.12.1. Company Overview
13.12.2. Financial Performance
13.12.3. Product Portfolio
13.12.4. Strategic Initiatives
13.13. DarioHealth Corp.
13.13.1. Company Overview
13.13.2. Financial Performance
13.13.3. Product Portfolio
13.13.4. Strategic Initiatives
13.14. BigHealth
13.14.1. Company Overview
13.14.2. Financial Performance
13.14.3. Product Portfolio
13.14.4. Strategic Initiatives
13.15. Gaia AG
13.15.1. Company Overview
13.15.2. Financial Performance
13.15.3. Product Portfolio
13.15.4. Strategic Initiatives
13.16. Limbix Health, Inc.
13.16.1. Company Overview
13.16.2. Financial Performance
13.16.3. Product Portfolio
13.16.4. Strategic Initiatives
13.17. Other Notable Players
13.17.1. Company Overview
13.17.2. Financial Performance
13.17.3. Product Portfolio
13.17.4. Strategic Initiatives
